References
- Diebold Y, Jarrín M, Sáez V, Carvalho EL, Orea M, Calonge M, Seijo B, Alonso MJ. (2007). Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials. 28:1553–64.
- Dutta T, Jain NK, Nigel, AJ, Parekh HS. (2010). Dendrimer nanocarriers as versatile vectors in gene delivery. Nanomed: Nanotechnol Biol Med. 6:25–34.
- Fatta E, Bochot A. (2008). State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. Int J Pharm. 364:237–48.
- Filipovic-Grcic J, Skalko-Basnet N, Jalsenjak I. (2001). Mucoadhesive chitosan-coated liposomes: characteristics and stability. J Microencaps. 18:3–12.
- Gonzalez-Rodriguez ML, Barros LB, Palmaa J, González-Rodríguez PL, Rabasco AM. (2007). Application of statistical experimental design to study the formulation variables influencing the coating process of lidocaine liposomes. Int J Pharm. 337:336–45.
- Guo J, Ping Q, Jiang G, Huang L, Tong Y. (2003). Chitosan-coated liposomes: characterization and interaction with leuprolide. Int J Pharm. 260:167–73.
- Jayakumar R, Chennazhi KP, Muzzarelli RA, Tamura H, Nair SV, Selvamurugan N. (2010). Chitosan conjugated DNA nanoparticles in gene therapy. Carbohyd Polym. 79:1–8.
- Kato C, Kajiwara T, Numazaki M, Takagi H, Kojima N (2008). Oligomannose-coated liposomes activate ERK via Src kinases and PI3K/Akt in J774A.1 cells. Biochem Biophys Res Commun. 372:898–901.
- Khatri K, Goyal AK, Gupta PN, Mishra N, Mehta A, Vyas SP. (2008). Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine. 26:2225–33.
- Leane MM, Nankervis R, Smith A, Illum L. (2004). Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms. Int J Pharm. 271:241–9.
- Lebedeva I, Benimetskaya L, Stein CA, Vilenchik M. (2000). Cellular delivery of antisense oligonucleotides. Eur J Pharm Biopharm. 50:101–19.
- Li N, Zhuang CY, Wang M, Sun X, Nie S, Pan W (2009). Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm. 379:131–8.
- Mao, S., Sun, W., Kissel, T. (2010). Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliver Rev. 62:12–27.
- Mintzer, M.A., Simanek, E.E. (2009). Nonviral vectors for gene delivery. Chem Rev. 109:259–302.
- Nafee N, Taetz S, Schneide M, Schaefer UF, Lehr CM. (2007). Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomed: Nanotechnol Biol Med. 3:173–83.
- Peng J, He X, Wang K, Tan W, Li H, Xing X, Wang Y. (2006). An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells. Nanomed: Nanotechnol Biol Med. 2:113–20.
- Pirollo KF, Rai A, Sleer LS, Chang EH. (2003). Antisense therapeutics: from theory to clinical practice. Pharm Ther. 99:55–77.
- Remaut K, Sanders NN, Geest BG, Braeckmans K, Demeester J. and De Smedt S.C. (2007). Nucleic acid delivery: where material sciences and bio-sciences meet. Mater Sci Eng R. 58:117–61.
- Springate CM, Jackson JK, Gleave ME, Burt HM. (2008). Clusterin antisense complexed with chitosan for controlled intratumoral delivery. Int J Pharm. 350:53–64.
- Tahara K, Sakai T, Yamamoto H, Takeuchi H, Kawashima Y (2008). Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery. Int J Pharm. 354:210–6.
- Venkatesan, N., Vyas, S.P. (2000). Polysaccharide coated liposomes for oral immunization -development and characterization. Int J Pharm. 203:169–77.
- Wasungu, L., Hoekstra, D. (2006). Cationic lipids, lipoplexes and intracellular delivery of genes. J Contr Rel. 116:255–64.
- Yaroslavov AA, Rakhnyanskaya AA, Yaroslavova EG, Efimova AA, Menger FM. (2008). Polyelectrolyte-coated liposomes: stabilization of the interfacial complexes. Adv Colloid Interfac. 142:43–52.
- Zaru, M., Manca, M.L., Fadda, A.M. (2009). Chitosan-coated liposomes for delivery to lungs by nebulisation. Colloids Surfaces B. 71:88–95.